A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2011
11/23/2011	CN101658489B Nalmefene hydrochloride injection and preparation method thereof
11/23/2011	CN101637486B Angelica dahurica coumarin extract as well as preparation method and quality control method thereof
11/23/2011	CN101564478B Medicament for treating peripheral facial paralysis and preparing method thereof
11/23/2011	CN101554370B Syringin for injection, preparation method and application thereof
11/23/2011	CN101497655B Polypeptide hydration salt compound and use for anti-depression aspect
11/23/2011	CN101336230B Pharmaceutical for use in the treatment of ureterolithiasis
11/23/2011	CN101265201B Method for synthesizing tramadol hydrochloride
11/22/2011	US8063233 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
11/22/2011	US8063220 Sulfonyl-quinoline derivatives
11/22/2011	US8063087 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
11/22/2011	US8063078 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
11/22/2011	US8063059 Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders
11/22/2011	US8063048 Acetylenyl-pyrazolo-pyrimidine derivatives
11/22/2011	US8063047 Pyridazine compounds and methods
11/22/2011	US8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
11/22/2011	US8062656 Methods of treating disease with nitric oxide (NO)-releasing polymers and soluble no-releasing nitrosamines
11/22/2011	US8061351 Dose dispensing system and apparatus
11/22/2011	CA2644750C Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process
11/22/2011	CA2606353C Alpha-methyl amino acid derivatives
11/22/2011	CA2509151C Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
11/22/2011	CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/22/2011	CA2480452C Thioxanthine derivatives as myeloperoxidase inhibitors
11/22/2011	CA2473874C A composition for treating neurocerebrovascular disorders
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2416808C Derivatives of branched-chain lipophilic molecules and uses thereof
11/22/2011	CA2352324C Derivatives of (-)-venlafaxine and methods of preparing and using the same
11/17/2011	WO2011143562A2 Il-1 binding proteins
11/17/2011	WO2011143526A2 Topical peripheral neuro-affective (tpna) therapy
11/17/2011	WO2011143495A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011143444A2 Diphenylbutypiperidine autophagy inducers
11/17/2011	WO2011143400A2 Method and composition for inducing human pluripotent stem cells
11/17/2011	WO2011143366A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011143365A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/17/2011	WO2011143360A2 Compositions, methods and systems for the synthesis and use of imaging agents
11/17/2011	WO2011143229A2 Lipid compositions and structured lipids containing phospholipids, oral formulations containing the same and methods of making the same
11/17/2011	WO2011143163A1 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
11/17/2011	WO2011143161A1 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
11/17/2011	WO2011143155A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
11/17/2011	WO2011143148A1 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
11/17/2011	WO2011143145A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
11/17/2011	WO2011143129A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors
11/17/2011	WO2011142716A1 Novel hemifumarate salt of isoindole compound acting as bace inhibitor
11/17/2011	WO2011142691A2 Method for producing a neural matrix
11/17/2011	WO2011142620A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants
11/17/2011	WO2011142618A2 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased
11/17/2011	WO2011142545A2 Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system
11/17/2011	WO2011142460A1 Method for detecting schizophrenia
11/17/2011	WO2011142445A1 Composition containing stabilized phosphatidylserine
11/17/2011	WO2011142381A1 Benzo- or pyrido-imidazole derivative
11/17/2011	WO2011142316A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity
11/17/2011	WO2011142246A1 Method for inhibition of potential-dependent cation channel
11/17/2011	WO2011141756A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
11/17/2011	WO2011141713A1 New bicyclic compounds as pi3-k and mtor inhibitors
11/17/2011	WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/17/2011	WO2011141396A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/17/2011	WO2011140998A1 Aralkyl diamine derivatives and uses thereof as antidepressant
11/17/2011	WO2011140997A1 Transgenic drosophila model of alzheimer's disease and use thereof in drug screening
11/17/2011	WO2011140981A1 Use of 5'-methoxy-3',4'-methylenedioxycinnamic acid isobutylamide on preparing medicaments for anti-depression
11/17/2011	WO2011140832A1 Hexaketide compound and medicinal use thereof
11/17/2011	WO2011140817A1 1-[(4-hydroxypridin-4-yl) methyl] pyridine-2(1h)-one derivatives, preparation methods and uses thereof
11/17/2011	WO2011140676A1 Rhizoma gastrodiae plant extract used to prevent and treat alzheimer disease and vascular dementia and mixed type diseases thereof and preparative method thereof
11/17/2011	WO2011140655A1 Phenolic compositions derived from apple skin and uses thereof
11/17/2011	WO2011140640A1 Selective glycosidase inhibitors and uses thereof
11/17/2011	WO2011140608A1 Neuropsychopharmacological treatment regimes for treating psychological disorders
11/17/2011	WO2011140607A1 A method of treatment and diagnosis
11/17/2011	WO2011119605A3 Morphinane derivatives containing a carboxamide group as opioid receptor ligands
11/17/2011	WO2011113798A3 Inhibitors of semicarabazide - sensitive amine oxidase
11/17/2011	WO2011104412A3 Compounds for treating alzheimer's disease
11/17/2011	WO2011090666A9 Methods for treating autism
11/17/2011	WO2011087804A3 Peptide- polynucleotide compositions for transfecting a cell with dna and for treating a neurodegenerative disease
11/17/2011	WO2011085162A3 Topical transdermal dexmedetomidine compositions and methods of use thereof
11/17/2011	WO2011084620A3 Particles for multiple agent delivery
11/17/2011	WO2011084434A3 Aza-ring fused indole and indoline derivatives
11/17/2011	WO2011031317A3 Vaccine for control of trypanosoma cruzi infection and chagas disease
11/17/2011	WO2011019763A3 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
11/17/2011	US20110281953 Process for preparing and drying solid rasagiline base
11/17/2011	US20110281951 Compositions and methods for treating amyloidosis
11/17/2011	US20110281949 Methods and compositions for treating neuronal damage and modulating transient receptor potential channels
11/17/2011	US20110281937 Methods and compositions for treating neuropathic and neurodegenerative conditions
11/17/2011	US20110281936 Methods of treating cognitive disorders by inhibition of gpr12
11/17/2011	US20110281933 Methods and compositions for the management of cardiovascular disease with oligonucleotides
11/17/2011	US20110281929 Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
11/17/2011	US20110281923 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
11/17/2011	US20110281914 Fentanyl composition for nasal administration
11/17/2011	US20110281911 Novel forms of eperisone
11/17/2011	US20110281905 Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor
11/17/2011	US20110281904 Use of Dextromethorphan in Treating Addictive Behavior or Bipolar Disorder
11/17/2011	US20110281903 Bicyclic heterocyclic spiro compounds
11/17/2011	US20110281897 Heterocyclic compounds and their uses
11/17/2011	US20110281894 Hemifumarate salt
11/17/2011	US20110281891 N-hydroxyamide derivatives and use thereof
11/17/2011	US20110281890 Piperidine and piperazine derivatives
11/17/2011	US20110281889 5-HT1A Receptor Subtype Agonist
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
11/17/2011	US20110281880 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers

1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 1833